GENERICO Revenue and Competitors

Mumbai, IND

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • GENERICO's estimated annual revenue is currently $34.9M per year.(i)
  • GENERICO's estimated revenue per employee is $100,500

Employee Data

  • GENERICO has 347 Employees.(i)
  • GENERICO grew their employee count by 46% last year.

GENERICO's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$56.6M56321%N/AN/A
#2
$15.6M15528%N/AN/A
#3
$17M169-11%N/AN/A
#4
$13.2M1318%N/AN/A
#5
$19.6M19510%N/AN/A
#6
$23.5M2347%N/AN/A
#7
$5.3M530%N/AN/A
#8
$13M129-25%N/AN/A
#9
$20.5M20411%N/AN/A
#10
$11.7M1166%N/AN/A
Add Company

What Is GENERICO?

GENERICO: Medicines at True Price. Generico is the fastest growing generic medicine focussed retail chain in Mumbai. Founded by IIT alums with a vision of providing affordable healthcare, by selling the highest quality generic medicines with maximum savings to our valued customers. Generico has already became the most trusted brand for more than 7,00,000 customers.

keywords:N/A

N/A

Total Funding

347

Number of Employees

$34.9M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GENERICO News

2022-04-06 - Kevin Owens' 10 Best Matches, According To CageMatch.net

El Generico & Colt Cabana (ROH Bitter Friends, Stiffer Enemies 2, 2010) - 9.04. Kevin Steen and Colt Cabana. Kevin Steen has always worked best...

2022-03-30 - WWE news: Sami Zayn gets brutally honest on his El Generico character

Sami Zayn made his name in the pro wrestling world with his 'El Generico' character, where he gained a cult following. Now, Zayn no longer wears...

2022-03-22 - Sami Zayn Suggests He Won't Be Bringing Back El Generico

It would be kind of awful to get El Generico to leave Mexico where he is building orphanges just to come on to WWE TV. Like I get Sami is a bad...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A34713%$113.7M
#2
$1.7M34922%N/A
#3
$37.9M3515%$6.7M
#4
$46.2M3529%N/A
#5
$71.7M3555%N/A